POSITIVE STOCKS GUIDE
Positive Biotech Stocks
Five plain checks for finding healthy companies to research.
Cash runwayTrial resultsDilution

What does a positive biotech stock look like?

Biotech companies build medicines, tests and treatments. Some sell products today. Many are still testing a first idea and have no sales yet. That makes biotech one of the hardest areas to judge, and one of the best places to practice careful research.

A positive biotech stock is a company that looks healthy on numbers you can check yourself. It is not a promise of gains. It is a way to decide which companies deserve your time.

How biotech companies make money

A biotech company usually earns money in one of three ways: selling an approved product, getting paid by a larger drug company for sharing a project, or earning research grants. A company with real sales and a few partners is usually on firmer ground than a company that depends on one test result.

Five checks to start with

1. Sales that are growing

Check sales or partner payments first. Revenue that grows year after year is a good sign. A company with no revenue is not automatically bad, but it needs more proof from other checks.

2. Cash that lasts

Cash runway matters most in biotech. Divide cash on hand by the money the company spends each quarter. If the answer is under about four quarters, expect the company to sell new shares soon.

Example only: months of cash leftCompany ACompany BLonger green bar means more time before the company must raise money.

3. Debt that is small

Debt is money the company must pay back. Compare it to the cash and to yearly earnings. High debt with low cash leaves little room for mistakes.

4. A share count that is not rising fast

When a company sells new shares, each existing share owns a smaller piece. Compare the share count today with a year ago. A big jump is called dilution. Read about it in dilution and reverse split warning signs.

5. A plan you can explain in one sentence

If you cannot say what the company does and how it will earn money, keep researching. Plain businesses are easier to judge.

Common risks in biotech

The biggest risk is a failed trial. One bad result can cut a share price in half in a day. Approval delays, new rules, and rivals with a better drug are the other common problems. Never put more into one trial story than you could afford to lose.

Many biotech names are small. Look at the trading volume. If few shares trade each day, it can be hard to sell when you want to.

A simple checklist before you go further

Common questions

Does a positive biotech stock mean the price will go up?

No. It means the company looks healthy on the numbers you can check. Prices move for many reasons.

Is a biotech with no sales always risky?

It is riskier, because everything depends on future results. Cash runway and debt tell you how long it can wait.

Where do I find cash and debt?

In the company balance sheet, in the quarterly report on the SEC site. Our glossary explains each term.

Get the free Positive Stocks brief

One short email with plain-English stock research ideas. Free, and you can leave any time.

Join free

Where to go next

Quick health check: look any company up on Simply Wall St to see its financial health in one picture. How we use it. We may earn a commission at no cost to you.

See our Biotech stocks to research, learn terms in the glossary, find names in the company directory, browse topics on StockVert, and read the Positive Stocks guide for the five signs in every sector. We use TradingView for charts, and may earn a commission.

Education only, not investment advice. Do your own research.